Table 5.
Results of cost-effectiveness analysis
| Referral indication (n) | Cost per life year saved discounted/undiscounted (USD) | ICER discounted/undiscounted |
| Obstructed labour (251) | 11.2/5.9 | 62.9/30.1 |
| Ineffective labour (137) | 11.7/6.2 | 115.1/54.7 |
| Extrauterine gravidity (50) | 14.4/8.0 | 14.4/8.0 |
| Postpartum haemorrhage (46) | 17.1/9.5 | 26.4/14.6 |
| Intrauterine fetal death (45) | 15.0/8.3 | 710.9/394.0 |
| Eclampsia (39) | 14.8/7.8 | 40.1/20.7 |
| Placenta previa (34) | 12.3/6.5 | 57.8/28.3 |
| Abortion (30) | 15.0/8.3 | 284.3/157.6 |
| Risk of premature delivery (26) | 11.0/5.8 | 72.9/32.7 |
| Placenta retention (25) | 14.3/7.9 | 171.3/94.9 |
| Delivery (22) | 10.4/5.4 | 288.5/138.9 |
| Infection post partum (19) | 59.9/33.2 | 379.1/210.1 |
| Risk of uterus rupture (17) | 10.9/5.7 | 15.6/8.0 |
| Fetal distress (12) | 10.3/5.3 | 76./34.5 |
| Malaria (12) | 10.3/5.3 | 447.8/217.8 |
| Respiratory distress neonate (12) | 170.2/75.8 | 227.0/101.0 |
| Neonatal infection (10) | 48.6/21.7 | 107.2/75.6 |
Costs per life-year saved (in USD) and ICER per diagnosis, undiscounted and discounted at 3%.
ICER, incremental cost-effectiveness ratios.